J. Gouveia

698 total citations
32 papers, 499 citations indexed

About

J. Gouveia is a scholar working on Oncology, Pathology and Forensic Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, J. Gouveia has authored 32 papers receiving a total of 499 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Oncology, 7 papers in Pathology and Forensic Medicine and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in J. Gouveia's work include Cancer Treatment and Pharmacology (9 papers), Chronic Lymphocytic Leukemia Research (4 papers) and Lymphoma Diagnosis and Treatment (4 papers). J. Gouveia is often cited by papers focused on Cancer Treatment and Pharmacology (9 papers), Chronic Lymphocytic Leukemia Research (4 papers) and Lymphoma Diagnosis and Treatment (4 papers). J. Gouveia collaborates with scholars based in France, Portugal and United States. J. Gouveia's co-authors include Patricia Ribaud, Michel P. Coleman, L Schwarzenberg, Nuno Lunet, Joana Bastos, Bárbara Peleteiro, G Mathé, M. Hayat, Misset Jl and D. Machover and has published in prestigious journals such as The Lancet, SHILAP Revista de lepidopterología and International Journal of Cancer.

In The Last Decade

J. Gouveia

32 papers receiving 468 citations

Peers

J. Gouveia
Comparison fields: 5 of 86
  • Oncology 207
  • Molecular Biology 146
  • Pulmonary and Respiratory Medicine 72
  • Public Health, Environmental and Occupational Health 68
  • Genetics 64
Replace D S Alberts with:
D S Alberts United States
Gudrun Windbichler Austria
Herman E. Kattlove United States
N Yamaguchi Brazil
Philip Iau Singapore
Michaëla Semeraro France
Jadwiga Rachtan Poland
Stefan de Vogel Netherlands
Renato Talamini Italy
I Pannacciulli Italy
D S Alberts United States View profile →
Citations per field, relative to J. Gouveia
J. Gouveia · 1×
Citations per year, relative to J. Gouveia
J. Gouveia · 1×

Countries citing papers authored by J. Gouveia

Since Specialization
Citations

This map shows the geographic impact of J. Gouveia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Gouveia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Gouveia more than expected).

Fields of papers citing papers by J. Gouveia

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Gouveia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Gouveia. The network helps show where J. Gouveia may publish in the future.

Co-authorship network of co-authors of J. Gouveia

This figure shows the co-authorship network connecting the top 25 collaborators of J. Gouveia. A scholar is included among the top collaborators of J. Gouveia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. Gouveia. J. Gouveia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Work Indexed citations
1 1
2 3
3 6
4 7
5 5
6 59
7 49
8
Anticardiolipin and antinuclear antibodies in cancer patients--a case control study.
23
9 3
10
Granulocyte-macrophage colony-stimulating factor in post-remission therapy of acute myeloid leukemia.
1
11 9
12
Regression of bronchial epidermoid metaplasia in heavy smokers with etretinate treatment.
57
13
[Treatment of leukemias and lymphomas with interferons: III. Trial treatment of meningeal localizations of acute leukemia and non-Hodgkin's lymphomas with beta interferon administered by the intrathecal route].
1
14
Treatment of lymphoid neoplasias with interferon. I. Human fibroblastic beta-interferon in malignant gammapathies. Phase II trial.
14
15 15
16 1
17
Phase II clinical trial with vindesine for remission induction in acute leukemia, blastic crisis of chronic myeloid leukemia, lymphosarcoma, and hodgkin's disease: absence of cross-resistance with vincristine.
47
18
[Leukaemias and lymphomas treatment by vindesine. Result of a phase II trial in terms of remission induction (author's transl)].
2
19 29
20 11

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026